System of coordinated care for osteoporotic patients in the Czech Republic

Vrablíková Květa, Palička Vladimír, Pikner Richard

Clin Osteol 2024; 29(1-2): 5-11

Osteoporosis is a population disease with a huge impact on the lives of individuals, but also on the health system. Increasing the proportion of seniors in our population is worsening the sustainability of the current management system of osteoporotic patients. Over the past 3 years, several new projects have been created to handle this situation. A strategy to reduce the number of osteoporotic fractures is being implemented, which involves a comprehensive restructuring of the osteoporotic patient care system as recommended by the International Osteoporosis Foundation (IOF). Recommended diagnostic and therapeutic procedures are updated, projects for...

Falls prevention -⁠ identification and intervention of risk factors

Greplová Kamila

Clin Osteol 2024; 29(1-2): 12-19

Falls and fall-related injuries are common in older adults, have negative effects on functional independence and quality of life and are associated with increased morbidity, mortality and health related costs. World guidelines for falls prevention and management for older adults: a global initiative were published in September 2022, which include an algorithm for fall risk stratification and patient assessment. For older people at high risk of falling, multifactorial falls risk assessment should be performed as a basis for subsequent targeted intervention. Examination should focus on history of fall, physical examination including gait assessment,...

Treatment by romosozumab in secondary osteoporosis: a review of the literature

Brunerová Ludmila

Clin Osteol 2024; 29(1-2): 20-24

Osteoporosis represents the most common metabolic bone disease, which affects every third woman and every fifth man worldwide. Low-trauma fractures represent the most serious complications of osteoporosis, responsible for significant morbidity, mortality and increased economical costs. Therapy of osteoporosis is based on three pillars -⁠ lifestyle changes, suplementation of vitamin D and calcium and specific antiosteoporotic treatment, which is able to decrease the fracture risk in a half. Romosozumab, a humanized monoclonal antibody against sclerostin has been the most recent anabolic treatment introduced to the Czech market. I tis indicated...

Acetabuloplasty in therapy of severe dysplasia of the hip: case report

Rendek Pavol; Halas Matúš; Kubičková Paulína; Bevilaqua Jana; Kokavec Milan

Clin Osteol 2024; 29(1-2): 25-28

Developmental dysplasia of the hip (DDH) is a prearthrotic hip defect requiring therapy from neonatal age. The Slovak population has an above-average incidence of DDH, which is why hip screening using the triple-screen method has been introduced in the Slovak Republic. When the most severe form of dysplasia is detected -⁠ hip luxa­tion and obstructions preventing the reposition of the femoral head into the acetabulum, surgical treatment is indicated. During surgery, evacuation of the acetabulum is performed, i.e. removal of all repositioning obstacles. Subsequently, a Dega acetabuloplasty and capsuloplasty are performed. In some cases, the femur...

Sborník abstrakt: XV. celostátní konference Sekundární osteoporóza, Plzeň, 10.-11. 5. 2024

Clin Osteol 2024; 29(1-2): 31-50

Výber z najnovších vedeckých informácií v osteológii

Šteňová Emoke

Clin Osteol 2024; 29(1-2): 29-30